{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:17:31Z","timestamp":1773281851318,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00347-012-2638-4","type":"journal-article","created":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T19:39:25Z","timestamp":1353613165000},"page":"1064-1070","source":"Crossref","is-referenced-by-count":19,"title":["Konservierungsmittel in der Ophthalmologie","Preservatives in ophthalmology"],"prefix":"10.1007","volume":"109","author":[{"given":"E. M.","family":"Messmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,21]]},"reference":[{"key":"2638_CR1","unstructured":"Deutsches Arzneibuch. 8, 123. 1978. Deutscher Apothekerverlag, Frankfurt, Govi, Stuttgart [Ref Type: Serial (Book, Monograph)]"},{"key":"2638_CR2","unstructured":"Brewitt H, Messmer EM, Geerling G (2007) Therapie des Trockenen Auges. In: Messmer EM (Hrsg) Diagnose und Therapie des Trockenen Auges. Uni-Med Verlag AG, Bremen, S\u00a087\u2013107"},{"key":"2638_CR3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","volume":"29","author":"Baudouin","year":"2010","unstructured":"Baudouin C, Labbe A, Liang H et al (2010) Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res 29:312\u2013334","journal-title":"Prog Retin Eye Res"},{"key":"2638_CR4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/01.ico.0000183538.53017.69","volume":"25","author":"Charnock","year":"2006","unstructured":"Charnock C (2006) Are multidose over-the-counter artificial tears adequately preserved? Cornea 25:432\u2013437","journal-title":"Cornea"},{"key":"2638_CR5","unstructured":"Champeau E, Edelhauser H (1986) Effect of ophthalmic preservatives on ocular surface: conjunctival and corneal uptake and distribution of benzalkonium chloride and chlorhexidine digluconate. In: Holly F (Hrsg) The preocular tear film. Dry Institute Inc., Lubbock"},{"key":"2638_CR6","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/BF02850204","volume":"23","author":"Friedlaender","year":"2006","unstructured":"Friedlaender MH, Breshears D, Amoozgar B et al (2006) The dilution of benzalkonium chloride (BAK) in the tear film. Adv Ther 23:835\u2013841","journal-title":"Adv Ther"},{"key":"2638_CR7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-2008-1054453","volume":"184","author":"Conrads","year":"1984","unstructured":"Conrads H, Winterhoff D, Strotmann U (1984) Pros and cons of preservatives in eyedrops. Questionnaire for practitioners and experimental studies with reference to the requirements of the German Pharmacopoeia of August 1978. Klin Monatsbl Augenheilkd 184:233\u2013237","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"2638_CR8","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1136\/bjo.2008.144469","volume":"92","author":"Kim","year":"2008","unstructured":"Kim MS, Choi CY, Kim JM et al (2008) Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers. Br J Ophthalmol 92:1518\u20131521","journal-title":"Br J Ophthalmol"},{"key":"2638_CR9","first-page":"162","volume":"9","author":"Tasli","year":"2001","unstructured":"Tasli H, Cosar G (2001) Microbial contamination of eye drops. Cent Eur J Public Health 9:162\u2013164","journal-title":"Cent Eur J Public Health"},{"key":"2638_CR10","unstructured":"EMEA public statement on antimicrobial preservatives in ophthalmic preparations for human use. EMEA\/622721\/2009. 8\u201312-2009. London (Ref Type: Report)"},{"key":"2638_CR11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/01.ijg.0000212274.50229.c6","volume":"16","author":"Lewis","year":"2007","unstructured":"Lewis RA, Katz GJ, Weiss MJ et al (2007) Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy. J Glaucoma 16:98\u2013103","journal-title":"J Glaucoma"},{"key":"2638_CR12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000192082","volume":"41","author":"Pellinen","year":"2009","unstructured":"Pellinen P, Lokkila J (2009) Corneal penetration into rabbit aqueous humor is comparable between preserved and preservative-free tafluprost. Ophthalmic Res 41:118\u2013122","journal-title":"Ophthalmic Res"},{"key":"2638_CR13","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1167\/iovs.07-0720","volume":"49","author":"Xiong","year":"2008","unstructured":"Xiong C, Chen D, Liu J et al (2008) A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride. Invest Ophthalmol Vis Sci 49:1850\u20131856","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2638_CR14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/bjo.79.4.339","volume":"79","author":"Kuppens","year":"1995","unstructured":"Kuppens EV, Jong CA de, Stolwijk TR et al (1995) Effect of timolol with and without preservative on the basal tear turnover in glaucoma. Br J Ophthalmol 79:339\u2013342","journal-title":"Br J Ophthalmol"},{"key":"2638_CR15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1076\/orbi.18.2.89.2717","volume":"18","author":"Kaercher","year":"1999","unstructured":"Kaercher T, Honig D, Barth W (1999) How the most common preservative affects the Meibomian lipid layer. Orbit 18:89\u201397","journal-title":"Orbit"},{"key":"2638_CR16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000310084","volume":"200","author":"Hoh","year":"1990","unstructured":"Hoh H (1990) Preservative-free timolol eye drops \u2013 surface-anesthetic effect and local compatibility. Ophthalmologica 200:89\u201397","journal-title":"Ophthalmologica"},{"key":"2638_CR17","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ajo.2008.10.019","volume":"147","author":"Martone","year":"2009","unstructured":"Martone G, Frezzotti P, Tosi GM et al (2009) An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology. Am J Ophthalmol 147:725\u2013735","journal-title":"Am J Ophthalmol"},{"key":"2638_CR18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ophtha.2005.10.050","volume":"113","author":"Chandrasekaran","year":"2006","unstructured":"Chandrasekaran S, Cumming RG, Rochtchina E, Mitchell P (2006) Associations between elevated intraocular pressure and glaucoma, use of glaucoma medications, and 5-year incident cataract: the Blue Mountains Eye Study. Ophthalmology 113:417\u2013424","journal-title":"Ophthalmology"},{"key":"2638_CR19","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ajo.2006.06.052","volume":"142","author":"Herman","year":"2006","unstructured":"Herman DC, Gordon MO, Beiser JA et al (2006) Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study. Am J Ophthalmol 142:800\u2013810","journal-title":"Am J Ophthalmol"},{"key":"2638_CR20","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/archopht.121.6.835","volume":"121","author":"Goto","year":"2003","unstructured":"Goto Y, Ibaraki N, Miyake K (2003) Human lens epithelial cell damage and stimulation of their secretion of chemical mediators by benzalkonium chloride rather than latanoprost and timolol. Arch Ophthalmol 121:835\u2013839","journal-title":"Arch Ophthalmol"},{"key":"2638_CR21","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0886-3350(03)00560-1","volume":"29","author":"Miyake","year":"2003","unstructured":"Miyake K, Ibaraki N, Goto Y et al (2003) ESCRS Binkhorst lecture 2002: pseudophakic preservative maculopathy. J Cataract Refract Surg 29:1800\u20131810","journal-title":"J Cataract Refract Surg"},{"key":"2638_CR22","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ophtha.2005.01.042","volume":"112","author":"Valk","year":"2005","unstructured":"Valk R van der, Webers CA, Schouten JS et al (2005) Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials. Ophthalmology 112:1177\u20131185","journal-title":"Ophthalmology"},{"key":"2638_CR23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1034\/j.1600-0536.2002.460510.x","volume":"46","author":"Corazza","year":"2002","unstructured":"Corazza M, Levratti A, Zampino MR, Virgili A (2002) Conventional patch tests are poor detectors of contact allergy from ophthalmic products. Contact Dermatitis 46:298\u2013299","journal-title":"Contact Dermatitis"},{"key":"2638_CR24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.0105-1873.2006.0645b.x","volume":"54","author":"Kalavala","year":"2006","unstructured":"Kalavala M, Statham BN (2006) Allergic contact dermatitis from timolol and dorzolamide eye drops. Contact Dermatitis 54:345","journal-title":"Contact Dermatitis"},{"key":"2638_CR25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.86.4.418","volume":"86","author":"Pisella","year":"2002","unstructured":"Pisella PJ, Pouliquen P, Baudouin C (2002) Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol 86:418\u2013423","journal-title":"Br J Ophthalmol"},{"key":"2638_CR26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/112067210701700311","volume":"17","author":"Jaenen","year":"2007","unstructured":"Jaenen N, Baudouin C, Pouliquen P et al (2007) Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol 17:341\u2013349","journal-title":"Eur J Ophthalmol"},{"key":"2638_CR27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00184009","volume":"232","author":"Jong","year":"1994","unstructured":"Jong C de, Stolwijk T, Kuppens E et al (1994) Topical timolol with and without benzalkonium chloride: epithelial permeability and autofluorescence of the cornea in glaucoma. Graefes Arch Clin Exp Ophthalmol 232:221\u2013224","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2638_CR28","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ophtha.2007.03.042","volume":"114","author":"Quigley","year":"2007","unstructured":"Quigley HA, Friedman DS, Hahn SR (2007) Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study. Ophthalmology 114:1599\u20131606","journal-title":"Ophthalmology"},{"key":"2638_CR29","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.survophthal.2008.08.002","volume":"53","author":"Schwartz","year":"2008","unstructured":"Schwartz GF, Quigley HA (2008) Adherence and persistence with glaucoma therapy. Surv Ophthalmol 53(Suppl1):S57\u2013S68","journal-title":"Surv Ophthalmol"},{"key":"2638_CR30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ajo.2003.10.035","volume":"137","author":"Reardon","year":"2004","unstructured":"Reardon G, Schwartz GF, Mozaffari E (2004) Patient persistency with topical ocular hypotensive therapy in a managed care population. Am J Ophthalmol 137:3\u201312","journal-title":"Am J Ophthalmol"},{"key":"2638_CR31","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.ajo.2003.10.034","volume":"137","author":"Schwartz","year":"2004","unstructured":"Schwartz GF, Reardon G, Mozaffari E (2004) Persistency with latanoprost or timolol in primary open-angle glaucoma suspects. Am J Ophthalmol 137:S13\u2013S16","journal-title":"Am J Ophthalmol"},{"key":"2638_CR32","first-page":"S262","volume":"8","author":"Spooner","year":"2002","unstructured":"Spooner JJ, Bullano MF, Ikeda LI et al (2002) Rates of discontinuation and change of glaucoma therapy in a managed care setting. Am J Manag Care 8:S262\u2013S270","journal-title":"Am J Manag Care"},{"key":"2638_CR33","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1755-3768.2008.01250.x","volume":"86","author":"Baudouin","year":"2008","unstructured":"Baudouin C (2008) Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma. Acta Ophthalmol 86:716\u2013726","journal-title":"Acta Ophthalmol"},{"key":"2638_CR34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00061198-200310000-00001","volume":"12","author":"Tsai","year":"2003","unstructured":"Tsai JC, McClure CA, Ramos SE et al (2003) Compliance barriers in glaucoma: a systematic classification. J Glaucoma 12:393\u2013398","journal-title":"J Glaucoma"},{"key":"2638_CR35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1477-7525-1-75","volume":"1","author":"Nordmann","year":"2003","unstructured":"Nordmann JP, Auzanneau N, Ricard S, Berdeaux G (2003) Vision related quality of life and topical glaucoma treatment side effects. Health Qual Life Outcomes 1:75","journal-title":"Health Qual Life Outcomes"},{"key":"2638_CR36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s12325-010-0070-1","volume":"27","author":"Ammar","year":"2010","unstructured":"Ammar DA, Noecker RJ, Kahook MY (2010) Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells. Adv Ther 27:837\u2013845","journal-title":"Adv Ther"},{"key":"2638_CR37","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.ico.0000116526.57227.82","volume":"23","author":"Noecker","year":"2004","unstructured":"Noecker RJ, Herrygers LA, Anwaruddin R (2004) Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea 23:490\u2013496","journal-title":"Cornea"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-012-2638-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-012-2638-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-012-2638-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T23:42:05Z","timestamp":1562370125000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-012-2638-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["2638"],"URL":"https:\/\/doi.org\/10.1007\/s00347-012-2638-4","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}